Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Lexeo Therapeutics, Inc.
organization2 mentionslast seen Sep 29, 2026
Clinical stage biopharmaceutical company focused on genetic diseases with high unmet need, based in New York City.
Relationships 9
- Lexeo Therapeutics, Inc.employsR. Nolan Townsend99% confidence2 sources
- Lexeo Therapeutics, Inc.acquiresMantle Therapeutics Inc.99% confidence1 source
- Lexeo Therapeutics, Inc.acquiresMantle Therapeutics Inc.97% confidence1 source
- Lexeo Therapeutics, Inc.developsSUNRISE-FA 296% confidence1 source
- Lexeo Therapeutics, Inc.developsLX202095% confidence1 source
- Lexeo Therapeutics, Inc.developsLX200695% confidence1 source
- Lexeo Therapeutics, Inc.partners withWeill Cornell Medicine94% confidence1 source
- Lexeo Therapeutics, Inc.partners withApertura Gene Therapy93% confidence1 source
- Lexeo Therapeutics, Inc.partners withVivet Therapeutics93% confidence1 source
Relationship
Lexeo Therapeutics, Inc.employsR. Nolan Townsend
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARSep 29, 2026Lexeo Therapeutics, Inc. 8-K: Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
R. Nolan Townsend, Chief Executive Officer
- filingSEC EDGARSep 22, 2026Lexeo Therapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
R. Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics